Corporate Overview

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products in the self-pay aesthetic market. Our first commercial product is Jeuveau®, a proprietary neurotoxin formulation used in adults to temporarily improve the appearance of moderate to severe frown lines between the eyebrows (glabellar lines). Supported by a unique business model and focus on the millennial demographic, Evolus is increasing its presence in the fast-growing aesthetic neurotoxin market while pursuing a strategy of becoming a leading, multi-product aesthetics company.

Read more

Evolysse™ Filler Distribution Agreement

Why Invest


Aesthetic neurotoxins are the largest segment of the $12B global medical aesthetics market1


Aesthetic neurotoxin usage among the 33M U.S. millennial women is currently very low2


70% of millennials are willing to spend money on maintaining or improving facial appearance3

  1. Medical Insights: The Global Aesthetic Market Study, September 2020
  2. Evolus U.S. Neurotoxin Market Research, December 2018
  3. Evolus Millennial Mindset Study, 2018
Learn more

Latest News

View all news

Investor Presentation

Latest Events

View All Events

Latest Quarterly Reports

View All Financial Reports